⌘K

Home/Filings/4/0000905718-22-000113

4//SEC Filing

Bradrick Brittany 4

Accession 0000905718-22-000113

CIK 0001853816other

View on SEC.gov Company Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 5:10 PM ET

Size

5.3 KB

Accession

0000905718-22-000113

Insider Transaction Report

Form 4

Period: 2022-01-12

Dermata Therapeutics, Inc.DRMA

Bradrick Brittany

Director

Transactions

Award
Stock Option (right to Buy)
2022-01-12+10,000→ 10,000 total
Exercise: $1.50Exp: 2032-01-11→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The option vests in twelve equal monthly installments commencing on January 12, 2022.

Documents

1 file

4
dermata_fm4jan122022.xmlPrimary

Issuer

Dermata Therapeutics, Inc.

CIK 0001853816

Entity typeother

Related Parties

1

filerCIK 0001904176

Filing Metadata

Form type: 4
Filed: Jan 13, 7:00 PM ET
Accepted: Jan 14, 5:10 PM ET
Size: 5.3 KB

View on SEC.gov